Shell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.00 Cr
- Satisfied Charges ₹ 16.45 Cr
- Revenue Growth 15.82%
- Profit Growth 71.46%
- Ebitda 67.86%
- Net Worth -9.30%
- Total Assets -30.09%
About Shell Pharmaceuticals
Shell Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 August 2009 and has a history of 15 years and five months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹35.00 Cr. The company has closed loans amounting to ₹16.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Manickam, Praveen Mishra, and Varun Mehta serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2009PTC072476
-
Company No.
072476
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Aug 2009
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Shell Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Manickam
|
Director | 27-Feb-2023 | Current |
| Praveen Mishra | Director | 11-Sep-2024 | Current |
| Varun Mehta | Director | 09-Jul-2024 | Current |
Financial Performance of Shell Pharmaceuticals.
Shell Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.82% increase. The company also saw a substantial improvement in profitability, with a 71.46% increase in profit. The company's net worth dipped by a decrease of 9.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shell Pharmaceuticals?
In 2020, Shell Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ahwspl India Private LimitedPraveen Mishra is a mutual person
-
Desai Pharma Distributors Private Limited
Praveen Mishra is a mutual person
-
Rau And Co Pharma Private LimitedSrinivasa Manickam and Varun Mehta are mutual person
-
Muthu Pharma Private Limited
Srinivasa Manickam and Varun Mehta are mutual person
-
Pearl Medicals Private Limited
Srinivasa Manickam and Varun Mehta are mutual person
-
Dial Health Drug Supplies Private Limited
Praveen Mishra is a mutual person
Charges (Loans)
₹350.00 M
₹164.50 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 35.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2019 | Axis Bank Limited | ₹35.00 Cr | Open |
| 21 Nov 2017 | Others | ₹7.20 Cr | Satisfied |
| 11 Jul 2017 | Hdfc Bank Limited | ₹4.50 Cr | Satisfied |
| 01 Mar 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.75 Cr | Satisfied |
| 16 Feb 2015 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
How Many Employees Work at Shell Pharmaceuticals?
Shell Pharmaceuticals has a workforce of 2 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
